|
|
|
Insider
Information: |
Mcdade Mark |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
5,912,376 |
|
Indirect Shares
|
741,691 |
|
|
Direct
Value |
$95,879,684 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
6,654,067 |
|
|
Total
Value |
$95,879,684 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
PDL Biopharma Inc |
PDLI |
CEO, Director |
2007-07-20 |
46,275 |
2004-06-04 |
0 |
Premium* |
|
Aimmune Therapeutics, Inc. |
AIMT |
Director |
2020-10-13 |
0 |
2015-08-11 |
0 |
Premium* |
|
Five Prime Therapeutics Inc |
FPRX |
Director |
2016-10-03 |
12,601 |
2016-10-03 |
0 |
Premium* |
|
Icosavax, Inc. |
ICVX |
|
2024-02-19 |
0 |
2024-02-19 |
0 |
Premium* |
|
Amplitude Healthcare Acquisition... |
AMHCU |
10% Owner |
2021-09-24 |
5,852,982 |
|
0 |
Premium* |
|
Tourmaline Bio |
TRML |
|
2024-01-29 |
518 |
2024-01-29 |
741,691 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
103 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 5
|
103 Records found
|
|
Page 5 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|